SSX2IP

Across TCGA pan-cancer cohorts, SSX2IP Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated SSX2IP data layer compared with 24 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher SSX2IP Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated SSX2IP expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC, ESCA, and SARC are the cancer types where SSX2IP Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	II,III,IV	1.000	0.429	.003	34	view →
ESCA	OS	Median	All	0.198	0.872	.003	18	view →
SARC	DFS	Median	All	0.069	0.632	<.001	12	view →
COAD	DFS	Median	II,III,IV	0.074	0.744	<.001	3	view →
LIHC	DFS	Median	All	0.096	0.526	.023	3	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

SSX2IP–UCEC (DFS)

Open the UCEC breakdown →